Fexofenadine HCl Tablets USP

Manufacturer: Meijer Distribution, Inc
Effective date: 2024-10-30
Label type: HUMAN OTC DRUG LABEL
Version: 4
Source: legacy-cache
Hydrated at: 2026-08-01 20:50:45

Label at a glance#

ProductFexofenadine Hydrochloride

Active ingredientFexofenadine Hydrochloride

Label structure11 sections

Dosage and administration

180 mg adults and children 12 years of age and over take one 180 mg tablet with water once a day; do not take more than 1 tablet in 24 hours children under 12 years of age do not use Adults 65 years of age and older ask a doctor consumers with kidney disease ask a doctor

Storage and handling

store between 20° - 25°C (68° - 77°F) protect from excessive moisture this product meets the requirements of USP Dissolution Test 2.

Contacts and useful links#

PhoneLabel contact1-888-375-3784

Label contents#

Full prescribing information#

SPL PRODUCT DATA ELEMENTS SECTION

SPL UNCLASSIFIED SECTION

Active ingredient(s)

OTC - ACTIVE INGREDIENT SECTION

Fexofenadine HCl USP, 180 mg

Purpose

OTC - PURPOSE SECTION

Antihistamine

Use(s)

INDICATIONS & USAGE SECTION

Allergy

temporarily relieves these symptoms due to hay fever or otherupper respiratory allergies:

runny nose
itchy, watery eyes
sneezing
itching of the nose or throat

Hives

reduces hives and relieves itching due to hives (urticaria). This product will not prevent hives or an allergic skin reaction from occuring.

Warnings

WARNINGS SECTION

Hives

Severe Allergic Warning: Get emergency help immediately if you have hives along with any of the following symptom:

trouble swallowing
dizziness or loss of consciousness
swelling of tongue
swelling in or around mouth
trouble speaking
drooling
wheezing or problems breathing

These symptoms may be signs of anaphylactic shock. This condition canbe life threatening if not treated by a health professional immediately.Symptoms of anaphylactic shock may occur when hives first appear or upto a few hours later.

Not a Substitute for Epinephrine. If your doctor has prescribed an epinephrineinjector for “anaphylaxis” or severe allergy symptoms that could occur withyour hives, never use this product as a substitute for the epinephrine injector.If you have been prescribed an epinephrine injector, you should carry it withyou at all times.

Do not use

OTC - DO NOT USE SECTION

Allergy

if you have ever had an allergic reaction to this product or any of its ingredients.

Hives

to prevent hives from any known cause such as:
- foods
- insect stings
- medicines
- latex or rubber gloves

because this product will not stop hives from occurring. Avoiding the cause of your hives is the only way to prevent them. Hives can sometimes be serious. If you do not know the cause of your hives, see your doctor for a medical exam. Your doctor may be able to help you find a cause.

if you have ever had an allergic reaction to this product or any of its ingredients

Ask a doctor before use if you have

OTC - ASK DOCTOR SECTION

Allergy

kidney disease. Your doctorshould determine if you need a different dose.

Hives

kidney disease. Your doctor should determine if you need a different dose.
hives that are an unusual color, look bruised or blistered
hives that do not itch

When using this product

OTC - WHEN USING SECTION

do not take more than directed
do not take at the same time as aluminum or magnesium antacids
do not take with fruit juices (see Directions)

Stop use and ask doctor if

OTC - STOP USE SECTION

Allergy

an allergic reaction to this product occurs. Seek medical help right away.

Hives

an allergic reaction to this product occurs. Seek medical help right away.
symptoms do not improve after 3 days of treatment
the hives have lasted more than 6 weeks

WARNINGS SECTION

If pregnant or breast-feeding

OTC - PREGNANCY OR BREAST FEEDING SECTION

ask a health professional before use.

Keep out of reach of children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

180 mg

adults and children 12 years of age and over	take one 180 mg tablet with water once a day; do not take more than 1 tablet in 24 hours
children under 12 years of age	do not use
Adults 65 years of age and older	ask a doctor
consumers with kidney disease	ask a doctor

Other information

SPL UNCLASSIFIED SECTION

safety sealed: do not use if carton is opened or if individual blister units are torn or opened.

Storage

STORAGE AND HANDLING SECTION

store between 20° - 25°C (68° - 77°F)

protect from excessive moisture

this product meets the requirements of USP Dissolution Test 2.

Inactive ingredients

INACTIVE INGREDIENT SECTION

colloidal silicon dioxide, corn starch, croscarmellose sodium, magnesium stearate, mannitol, and powdered cellulose, opadry pink 03B54504 containing FD&C Red no. 40, hypromellose, iron oxide black, polyethylene glycol and titanium dioxide.

Questions or comments?

OTC - QUESTIONS SECTION

call toll-free 1-888-375-3784

Manufactured by:

Dr. Reddy’s Laboratories Limited

Bachupally - 500 090 INDIA

Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Container Carton Label: 30 count

containercarton

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
41250-784	FEXOFENADINE HYDROCHLORIDE TABLET [MEIJER DISTRIBUTION, INC]	4	Legacy NDC	20241101_2fdeb5fb-1e79-5049-d37e-451f7d7db482.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
55111-784-01	EA - Each	55111-784	fcfbe779-dfaf-4c1a-b197-12b0a5ca5247	1	2018-12-13
55111-784-30	EA - Each	55111-784	9ca6ce31-a274-408f-b03e-0b74b74bc4fd	1	2015-09-10

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
Fexofenadine Hydrochloride	ACTIVE INGREDIENT	2S068B75ZU	1
FEXOFENADINE	ACTIVE MOIETY	E6582LOH6V	1
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	1
FD&C RED NO. 40	INACTIVE INGREDIENT	WZB9127XOA	1
FERROSOFERRIC OXIDE	INACTIVE INGREDIENT	XM0M87F357	1
HYPROMELLOSE 2910 (6 MPA.S)	INACTIVE INGREDIENT	0WZ8WG20P6	1
magnesium stearate	INACTIVE INGREDIENT	70097M6I30	1
mannitol	INACTIVE INGREDIENT	3OWL53L36A	1
polyethylene glycol 400	INACTIVE INGREDIENT	B697894SGQ	1
POWDERED CELLULOSE	INACTIVE INGREDIENT	SMD1X3XO9M	1
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	1
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	1
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 13 matching rows.

Fexofenadine Hydrochloride
FEXOFENADINE
SILICON DIOXIDE
CROSCARMELLOSE SODIUM
magnesium stearate
mannitol
POWDERED CELLULOSE
FD&C RED NO. 40
HYPROMELLOSE 2910 (6 MPA.S)
FERROSOFERRIC OXIDE
polyethylene glycol 400
TITANIUM DIOXIDE
STARCH, CORN

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
41250-784	41250-784-30, 41250-784-90, 41250-784-01
55111-784

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 12 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
Fexofenadine Hydrochloride	2S068B75ZU	ACTIB
SILICON DIOXIDE	ETJ7Z6XBU4	IACT
CROSCARMELLOSE SODIUM	M28OL1HH48	IACT
magnesium stearate	70097M6I30	IACT
mannitol	3OWL53L36A	IACT
POWDERED CELLULOSE	SMD1X3XO9M	IACT
FD&C RED NO. 40	WZB9127XOA	IACT
HYPROMELLOSE 2910 (6 MPA.S)	0WZ8WG20P6	IACT
FERROSOFERRIC OXIDE	XM0M87F357	IACT
polyethylene glycol 400	B697894SGQ	IACT
TITANIUM DIOXIDE	15FIX9V2JP	IACT
STARCH, CORN	O8232NY3SJ	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 11 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Maximum daily exposure	Match
FERROSOFERRIC OXIDE	FERROSOFERRIC OXIDE	XM0M87F357	TABLET / ORAL	2 mg	Exact identifier — unii+route+dosage form
mannitol	MANNITOL	3OWL53L36A	TABLET / ORAL	3391 mg	Exact identifier — unii+route+dosage form
polyethylene glycol 400	POLYETHYLENE GLYCOL 400	B697894SGQ	TABLET / ORAL	193 mg	Exact identifier — unii+route+dosage form
FD&C RED NO. 40	FD&C RED NO. 40	WZB9127XOA	TABLET / ORAL	7 mg	Exact identifier — unii+route+dosage form
CROSCARMELLOSE SODIUM	CROSCARMELLOSE SODIUM	M28OL1HH48	TABLET / ORAL	736 mg	Exact identifier — unii+route+dosage form
STARCH, CORN	STARCH, CORN	O8232NY3SJ	TABLET / ORAL	1116 mg	Exact identifier — unii+route+dosage form
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET / ORAL	750 mg	Exact identifier — unii+route+dosage form
magnesium stearate	MAGNESIUM STEARATE	70097M6I30	TABLET / ORAL	980 mg	Exact identifier — unii+route+dosage form
POWDERED CELLULOSE	POWDERED CELLULOSE	SMD1X3XO9M	TABLET / ORAL	1582 mg	Exact identifier — unii+route+dosage form
HYPROMELLOSE 2910 (6 MPA.S)	HYPROMELLOSE 2910 (6 MPA.S)	0WZ8WG20P6	TABLET / ORAL	880 mg	Exact identifier — unii+route+dosage form
TITANIUM DIOXIDE	TITANIUM DIOXIDE	15FIX9V2JP	TABLET / ORAL	232 mg	Exact identifier — unii+route+dosage form

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 9 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	Approval date
A076502-001	FEXOFENADINE HYDROCHLORIDE	FEXOFENADINE HYDROCHLORIDE	30MG	TABLET / ORAL	2006-04-11
A076502-002	FEXOFENADINE HYDROCHLORIDE	FEXOFENADINE HYDROCHLORIDE	60MG	TABLET / ORAL	2006-04-11
A076502-003	FEXOFENADINE HYDROCHLORIDE	FEXOFENADINE HYDROCHLORIDE	180MG	TABLET / ORAL	2006-04-11
A076502-004	CHILDREN'S FEXOFENADINE HYDROCHLORIDE ALLERGY	FEXOFENADINE HYDROCHLORIDE	30MG	TABLET / ORAL	2011-04-12
A076502-005	CHILDREN'S FEXOFENADINE HYDROCHLORIDE HIVES	FEXOFENADINE HYDROCHLORIDE	30MG	TABLET / ORAL	2011-04-12
A076502-006	FEXOFENADINE HYDROCHLORIDE ALLERGY	FEXOFENADINE HYDROCHLORIDE	60MG	TABLET / ORAL	2011-04-12
A076502-007	FEXOFENADINE HYDROCHLORIDE HIVES	FEXOFENADINE HYDROCHLORIDE	60MG	TABLET / ORAL	2011-04-12
A076502-008	FEXOFENADINE HYDROCHLORIDE ALLERGY	FEXOFENADINE HYDROCHLORIDE	180MG	TABLET / ORAL	2011-04-12
A076502-009	FEXOFENADINE HYDROCHLORIDE HIVES	FEXOFENADINE HYDROCHLORIDE	180MG	TABLET / ORAL	2011-04-12

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 10 · 387 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	A076502-001	FEXOFENADINE HYDROCHLORIDE	30MG	TABLET / ORAL		2006-04-11	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A076502-002	FEXOFENADINE HYDROCHLORIDE	60MG	TABLET / ORAL		2006-04-11	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A076502-003	FEXOFENADINE HYDROCHLORIDE	180MG	TABLET / ORAL		2006-04-11	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A076502-004	CHILDREN'S FEXOFENADINE HYDROCHLORIDE ALLERGY	30MG	TABLET / ORAL		2011-04-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A076502-005	CHILDREN'S FEXOFENADINE HYDROCHLORIDE HIVES	30MG	TABLET / ORAL		2011-04-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A076502-006	FEXOFENADINE HYDROCHLORIDE ALLERGY	60MG	TABLET / ORAL		2011-04-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A076502-007	FEXOFENADINE HYDROCHLORIDE HIVES	60MG	TABLET / ORAL		2011-04-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A076502-008	FEXOFENADINE HYDROCHLORIDE ALLERGY	180MG	TABLET / ORAL		2011-04-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A076502-009	FEXOFENADINE HYDROCHLORIDE HIVES	180MG	TABLET / ORAL		2011-04-12	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A076502-001	FEXOFENADINE HYDROCHLORIDE	30MG	TABLET / ORAL		2006-04-11	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A076502-002	FEXOFENADINE HYDROCHLORIDE	60MG	TABLET / ORAL		2006-04-11	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A076502-003	FEXOFENADINE HYDROCHLORIDE	180MG	TABLET / ORAL		2006-04-11	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A076502-004	CHILDREN'S FEXOFENADINE HYDROCHLORIDE ALLERGY	30MG	TABLET / ORAL		2011-04-12	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A076502-005	CHILDREN'S FEXOFENADINE HYDROCHLORIDE HIVES	30MG	TABLET / ORAL		2011-04-12	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A076502-006	FEXOFENADINE HYDROCHLORIDE ALLERGY	60MG	TABLET / ORAL		2011-04-12	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A076502-007	FEXOFENADINE HYDROCHLORIDE HIVES	60MG	TABLET / ORAL		2011-04-12	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A076502-008	FEXOFENADINE HYDROCHLORIDE ALLERGY	180MG	TABLET / ORAL		2011-04-12	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A076502-009	FEXOFENADINE HYDROCHLORIDE HIVES	180MG	TABLET / ORAL		2011-04-12	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A076502-001	FEXOFENADINE HYDROCHLORIDE	30MG	TABLET / ORAL	AB	2006-04-11	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A076502-002	FEXOFENADINE HYDROCHLORIDE	60MG	TABLET / ORAL	AB	2006-04-11	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A076502-003	FEXOFENADINE HYDROCHLORIDE	180MG	TABLET / ORAL	AB	2006-04-11	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A076502-004	CHILDREN'S FEXOFENADINE HYDROCHLORIDE ALLERGY	30MG	TABLET / ORAL		2011-04-12	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A076502-005	CHILDREN'S FEXOFENADINE HYDROCHLORIDE HIVES	30MG	TABLET / ORAL		2011-04-12	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A076502-006	FEXOFENADINE HYDROCHLORIDE ALLERGY	60MG	TABLET / ORAL		2011-04-12	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A076502-007	FEXOFENADINE HYDROCHLORIDE HIVES	60MG	TABLET / ORAL		2011-04-12	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A076502-008	FEXOFENADINE HYDROCHLORIDE ALLERGY	180MG	TABLET / ORAL		2011-04-12	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A076502-009	FEXOFENADINE HYDROCHLORIDE HIVES	180MG	TABLET / ORAL		2011-04-12	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076502-001	FEXOFENADINE HYDROCHLORIDE	30MG	TABLET / ORAL	AB	2006-04-11	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076502-002	FEXOFENADINE HYDROCHLORIDE	60MG	TABLET / ORAL	AB	2006-04-11	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076502-003	FEXOFENADINE HYDROCHLORIDE	180MG	TABLET / ORAL	AB	2006-04-11	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076502-004	CHILDREN'S FEXOFENADINE HYDROCHLORIDE ALLERGY	30MG	TABLET / ORAL		2011-04-12	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076502-005	CHILDREN'S FEXOFENADINE HYDROCHLORIDE HIVES	30MG	TABLET / ORAL		2011-04-12	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076502-006	FEXOFENADINE HYDROCHLORIDE ALLERGY	60MG	TABLET / ORAL		2011-04-12	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076502-007	FEXOFENADINE HYDROCHLORIDE HIVES	60MG	TABLET / ORAL		2011-04-12	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076502-008	FEXOFENADINE HYDROCHLORIDE ALLERGY	180MG	TABLET / ORAL		2011-04-12	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076502-009	FEXOFENADINE HYDROCHLORIDE HIVES	180MG	TABLET / ORAL		2011-04-12	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A076502-001	FEXOFENADINE HYDROCHLORIDE	30MG	TABLET / ORAL	AB	2006-04-11	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A076502-002	FEXOFENADINE HYDROCHLORIDE	60MG	TABLET / ORAL	AB	2006-04-11	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A076502-003	FEXOFENADINE HYDROCHLORIDE	180MG	TABLET / ORAL	AB	2006-04-11	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A076502-004	CHILDREN'S FEXOFENADINE HYDROCHLORIDE ALLERGY	30MG	TABLET / ORAL		2011-04-12	`6a471c1ec25d…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 120 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A076502-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A076502-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A076502-003	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076502-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076502-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076502-003	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A076502-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A076502-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A076502-003	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A076502-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A076502-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A076502-003	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A076502-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A076502-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A076502-003	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A076502-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A076502-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A076502-003	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A076502-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A076502-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A076502-003	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A076502-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A076502-002	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A076502-003	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A076502-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A076502-002	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A076502-003	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A076502-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A076502-002	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A076502-003	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A076502-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A076502-002	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A076502-003	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A076502-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A076502-002	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A076502-003	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A076502-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A076502-002	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A076502-003	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A076502-001	AB	1	`8072bd15b7f6…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Fexofenadine hydrochloride	FEXOFENADINE HYDROCHLORIDE	Dr. Reddy's Laboratories Limited	864e3052-5787-bf11-9d17-11274ca2304f	2026-07-09	Warnings	Exact identifier ndc (product): 55111-784
d2a65b15-6eed-1d04-7270-ae184be34cfa			2fdeb5fb-1e79-5049-d37e-451f7d7db482	2025-07-18	Warnings	Exact identifier spl set id: 2fdeb5fb-1e79-5049-d37e-451f7d7db482

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.